Please Wait
Applying Filters...
menu
    • menu
    Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

    Data Compilation
    #PharmaFlow

    Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

    Stock Recap
    #PipelineProspector

    Menu

    3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 30,736Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    31/10/2025 Changzhou Pharmaceutical Factory
    China
    		 Sampoong Pharmachem Co., Ltd. Su582-13-ND Lenalidomide 2023-11-27 Changzhou Pharmaceutical Factory China No.518 Laodong East Road, Changzhou, Jiangsu Province, PR China
    31/10/2025 Cipla
    India
    		 UNUST Co., Ltd. Su496-21-ND Lenalidomide 2017-04-07 Cipla limited India Plot No. 285, 286, 287, KIADB 4th Phase, Industrial Area, Bommasandra-Jigani Link Road, Bangalore-560105, India